Abstract
Abandonment of the classic radical mastectomy is not warranted at present. Excision of the internal mammary nodes can be defended in cases in which the cancer is situated in the medial or central part of the breast, with the recognition that it is experimental. Controlled cooperative trials would do much to answer the unsolved questions regarding the care of patients with breast cancer.